| Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... The Lancet 397 (10269), 99-111, 2021 | 5293 | 2021 |
| Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four … M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... The Lancet 397 (10277), 881-891, 2021 | 1333 | 2021 |
| Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults H Lal, AL Cunningham, O Godeaux, R Chlibek, J Diez-Domingo, ... New England Journal of Medicine 372 (22), 2087-2096, 2015 | 1330 | 2015 |
| Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older AL Cunningham, H Lal, M Kovac, R Chlibek, SJ Hwang, J Díez-Domingo, ... New England Journal of Medicine 375 (11), 1019-1032, 2016 | 980 | 2016 |
| Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority … SAC Clemens, L Weckx, R Clemens, AVA Mendes, AR Souza, ... The Lancet 399 (10324), 521-529, 2022 | 377 | 2022 |
| Respiratory viruses and influenza-like illness: epidemiology and outcomes in children aged 6 months to 10 years in a multi-country population sample S Taylor, P Lopez, L Weckx, C Borja-Tabora, R Ulloa-Gutierrez, ... Journal of Infection 74 (1), 29-41, 2017 | 158 | 2017 |
| Immune responses to a recombinant glycoprotein E herpes zoster vaccine in adults aged 50 years or older AL Cunningham, TC Heineman, H Lal, O Godeaux, R Chlibek, SJ Hwang, ... The Journal of infectious diseases 217 (11), 1750-1760, 2018 | 149 | 2018 |
| Immunophenotypic characterization of peripheral T lymphocytes in Mycobacterium tuberculosis infection and disease DSS Rodrigues, EAS Medeiros, LY Weckx, W Bonnez, R Salomão, ... Clinical & Experimental Immunology 128 (1), 149-154, 2002 | 137 | 2002 |
| Oxford COVID Vaccine Trial Group Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in … M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... Lancet 397 (10269), 99-111, 2021 | 133 | 2021 |
| Respirador bucal: causas e consequências LLM Weckx, LY Weckx Rev Bras Med 52 (8), 863-74, 1995 | 71 | 1995 |
| Prevalence and incidence of respiratory syncytial virus and other respiratory viral infections in children aged 6 months to 10 years with influenza-like illness enrolled in a … T Nolan, C Borja-Tabora, P Lopez, L Weckx, R Ulloa-Gutierrez, ... Clinical Infectious Diseases 60 (11), e80-e89, 2015 | 63 | 2015 |
| Reduced schedules of 4CMenB vaccine in infants and catch-up series in children: Immunogenicity and safety results from a randomised open-label phase 3b trial F Martinón-Torres, MAP Safadi, AC Martinez, PI Marquez, JCT Torres, ... Vaccine 35 (28), 3548-3557, 2017 | 58 | 2017 |
| Tetanus and diphtheria antibodies and response to a booster dose in Brazilian HIV-1-infected women TCS Bonetti, RCM Succi, LY Weckx, L Tavares-Lopes, ... Vaccine 22 (27-28), 3707-3712, 2004 | 52 | 2004 |
| Immunogenicity and tolerability of hepatitis A vaccine in HIV-infected children AFTB Gouvêa, MI De Moraes-Pinto, E Ono, MIS Dinelli, DM Machado, ... Clinical infectious diseases 41 (4), 544-548, 2005 | 50 | 2005 |
| Effectiveness of the human papillomavirus (types 6, 11, 16, and 18) vaccine in the treatment of children with recurrent respiratory papillomatosis JS Hermann, LY Weckx, JM Nürmberger, GFDS Junior, ACC Pignatari, ... International journal of pediatric otorhinolaryngology 83, 94-98, 2016 | 46 | 2016 |
| Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil SAC Clemens, PM Folegatti, KRW Emary, LY Weckx, J Ratcliff, S Bibi, ... Nature Communications 12 (1), 5861, 2021 | 45 | 2021 |
| Imunizaçöes: fundamentos e prática CK Farhat, ES Carvalho, LY Weckx, LHFR Carvalho, RCM Succi Imunizaçöes: fundamentos e prática, 635-635, 2000 | 45 | 2000 |
| Safety profile of the adjuvanted recombinant zoster vaccine: pooled analysis of two large randomised phase 3 trials M López-Fauqued, L Campora, F Delannois, M El Idrissi, L Oostvogels, ... Vaccine 37 (18), 2482-2493, 2019 | 44 | 2019 |
| Rubella immunization in human immunodeficiency virus type 1-infected children: cause for concern in vaccination strategies M Lima, RC de Menezes Succi, AMN Dos Santos, LY Weckx, ... The Pediatric infectious disease journal 23 (7), 604-607, 2004 | 42 | 2004 |
| Relative efficacy of AS03-adjuvanted pandemic influenza A (H1N1) vaccine in children: results of a controlled, randomized efficacy trial T Nolan, S Roy-Ghanta, M Montellano, L Weckx, R Ulloa-Gutierrez, ... The Journal of infectious diseases 210 (4), 545-557, 2014 | 36 | 2014 |
